Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination.

Saved in:
Bibliographic Details
Title: Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination.
Authors: Orrù V; Institute for Genetic and Biomedical Research, National Research Council, Lanusei, Italy., Serra V; Institute for Genetic and Biomedical Research, National Research Council, Lanusei, Italy., Marongiu M; Institute for Genetic and Biomedical Research, National Research Council, Lanusei, Italy., Lai S; Institute for Genetic and Biomedical Research, National Research Council, Lanusei, Italy., Lodde V; Department of Biomedical Sciences, University of Sassari, Sassari, Italy., Zoledziewska M; Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Italy., Steri M; Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Italy., Loizedda A; Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Italy., Lobina M; Institute for Genetic and Biomedical Research, National Research Council, Lanusei, Italy., Piras MG; Institute for Genetic and Biomedical Research, National Research Council, Lanusei, Italy., Virdis F; Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Italy., Delogu G; Department of Biomedical Sciences, University of Sassari, Sassari, Italy., Marini MG; Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Italy., Mingoia M; Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Italy., Floris M; Department of Biomedical Sciences, University of Sassari, Sassari, Italy., Masala M; Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Italy., Castelli MP; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy., Mostallino R; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy., Frau J; Regional Multiple Sclerosis Center, Azienda Sanitaria Locale (ASL) Cagliari, Cagliari, Italy., Lorefice L; Regional Multiple Sclerosis Center, Azienda Sanitaria Locale (ASL) Cagliari, Cagliari, Italy., Farina G; Neurology Unit, Azienza Ospedaliera Universitaria (AOU) Sassari, Sassari, Italy., Fronza M; Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy., Carmagnini D; Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy., Carta E; Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy., Pilotto S; Neurology Unit, Azienza Ospedaliera Universitaria (AOU) Sassari, Sassari, Italy.; Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy., Chessa P; Neurology Unit, Azienza Ospedaliera Universitaria (AOU) Sassari, Sassari, Italy.; Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy., Devoto M; Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Italy.; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Castiglia P; Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy., Solla P; Neurology Unit, Azienza Ospedaliera Universitaria (AOU) Sassari, Sassari, Italy.; Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy., Zarbo RI; Neurology Unit, Azienza Ospedaliera Universitaria (AOU) Sassari, Sassari, Italy.; Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy., Idda ML; Department of Biomedical Sciences, University of Sassari, Sassari, Italy., Pitzalis M; Institute for Genetic and Biomedical Research, National Research Council, Monserrato, Italy., Cocco E; Regional Multiple Sclerosis Center, Azienda Sanitaria Locale (ASL) Cagliari, Cagliari, Italy.; Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy., Fiorillo E; Institute for Genetic and Biomedical Research, National Research Council, Lanusei, Italy., Cucca F; Institute for Genetic and Biomedical Research, National Research Council, Lanusei, Italy.; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Source: Frontiers in immunology [Front Immunol] 2024 Jul 15; Vol. 15, pp. 1416464. Date of Electronic Publication: 2024 Jul 15 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1416464